Join
Live feed
·
INSIDERFilingvia Quantisnow
MIRA Pharmaceuticals Inc. logo

Chief Executive Officer Aminov Erez was granted 2,685,456 shares, increasing direct ownership by 318% to 3,530,156 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MIRA· MIRA Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MIRA (MIRA Pharmaceuticals Inc.) and more on Quantisnow.